StockData
Entera Bio Ltd. logo

Entera Bio Ltd. (ENTX) income statement

ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$3.31+0.03 (+0.76%)

Close on Nov 20, 2026Market cap $572.23MP/E –Yield –

See a number that looks wrong?